OLEMA PHARMACEUTICALS INC (OLMA) Fundamental Analysis & Valuation

NASDAQ:OLMA • US68062P1066

Current stock price

14.91 USD
+1.49 (+11.1%)
At close:
14.91 USD
0 (0%)
After Hours:

This OLMA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. OLMA Profitability Analysis

1.1 Basic Checks

  • OLMA had negative earnings in the past year.
  • In the past year OLMA has reported a negative cash flow from operations.
  • In the past 5 years OLMA always reported negative net income.
  • OLMA had a negative operating cash flow in each of the past 5 years.
OLMA Yearly Net Income VS EBIT VS OCF VS FCFOLMA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M

1.2 Ratios

  • With a decent Return On Assets value of -30.45%, OLMA is doing good in the industry, outperforming 65.96% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -33.95%, OLMA is in the better half of the industry, outperforming 72.53% of the companies in the same industry.
Industry RankSector Rank
ROA -30.45%
ROE -33.95%
ROIC N/A
ROA(3y)-31.35%
ROA(5y)-33.34%
ROE(3y)-34.56%
ROE(5y)-36.34%
ROIC(3y)N/A
ROIC(5y)N/A
OLMA Yearly ROA, ROE, ROICOLMA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K -4K

1.3 Margins

  • OLMA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OLMA Yearly Profit, Operating, Gross MarginsOLMA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. OLMA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for OLMA has been increased compared to 1 year ago.
  • OLMA has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, OLMA has a worse debt to assets ratio.
OLMA Yearly Shares OutstandingOLMA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
OLMA Yearly Total Debt VS Total AssetsOLMA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • OLMA has an Altman-Z score of 9.91. This indicates that OLMA is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of OLMA (9.91) is better than 82.40% of its industry peers.
  • OLMA has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • OLMA's Debt to Equity ratio of 0.01 is in line compared to the rest of the industry. OLMA outperforms 47.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 9.91
ROIC/WACCN/A
WACCN/A
OLMA Yearly LT Debt VS Equity VS FCFOLMA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

  • A Current Ratio of 9.95 indicates that OLMA has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 9.95, OLMA is in the better half of the industry, outperforming 79.11% of the companies in the same industry.
  • A Quick Ratio of 9.95 indicates that OLMA has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 9.95, OLMA is doing good in the industry, outperforming 79.30% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 9.95
Quick Ratio 9.95
OLMA Yearly Current Assets VS Current LiabilitesOLMA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. OLMA Growth Analysis

3.1 Past

  • OLMA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.84%, which is quite good.
EPS 1Y (TTM)15.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1.96%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • OLMA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.98% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-23.94%
EPS Next 2Y-18.71%
EPS Next 3Y-9.59%
EPS Next 5Y2.98%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OLMA Yearly Revenue VS EstimatesOLMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B
OLMA Yearly EPS VS EstimatesOLMA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 -0.5 -1 -1.5 -2 -2.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. OLMA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for OLMA. In the last year negative earnings were reported.
  • Also next year OLMA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OLMA Price Earnings VS Forward Price EarningsOLMA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OLMA Per share dataOLMA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • OLMA's earnings are expected to decrease with -9.59% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-18.71%
EPS Next 3Y-9.59%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. OLMA Dividend Analysis

5.1 Amount

  • No dividends for OLMA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OLMA Fundamentals: All Metrics, Ratios and Statistics

OLEMA PHARMACEUTICALS INC

NASDAQ:OLMA (3/31/2026, 4:30:02 PM)

After market: 14.91 0 (0%)

14.91

+1.49 (+11.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-16
Earnings (Next)05-11
Inst Owners109.95%
Inst Owner Change31.31%
Ins Owners2.84%
Ins Owner Change-11.29%
Market Cap1.17B
Revenue(TTM)N/A
Net Income(TTM)-162.45M
Analysts86.67
Price Target42.33 (183.9%)
Short Float %10.81%
Short Ratio4.73
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.98%
Min EPS beat(2)0.67%
Max EPS beat(2)7.28%
EPS beat(4)3
Avg EPS beat(4)1.44%
Min EPS beat(4)-32.98%
Max EPS beat(4)30.8%
EPS beat(8)5
Avg EPS beat(8)3.72%
EPS beat(12)8
Avg EPS beat(12)5.69%
EPS beat(16)11
Avg EPS beat(16)4.55%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.42%
PT rev (3m)-9.04%
EPS NQ rev (1m)-2.11%
EPS NQ rev (3m)3.69%
EPS NY rev (1m)1.64%
EPS NY rev (3m)4.64%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-22.23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.45
P/tB 2.45
EV/EBITDA N/A
EPS(TTM)-1.86
EYN/A
EPS(NY)-2.31
Fwd EYN/A
FCF(TTM)-1.87
FCFYN/A
OCF(TTM)-1.87
OCFYN/A
SpS0
BVpS6.08
TBVpS6.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -30.45%
ROE -33.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-31.35%
ROA(5y)-33.34%
ROE(3y)-34.56%
ROE(5y)-36.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.95
Quick Ratio 9.95
Altman-Z 9.91
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1.96%
EPS Next Y-23.94%
EPS Next 2Y-18.71%
EPS Next 3Y-9.59%
EPS Next 5Y2.98%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-25.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-17.47%
EBIT Next 3YN/A
EBIT Next 5Y24.13%
FCF growth 1Y-40.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-40.6%
OCF growth 3YN/A
OCF growth 5YN/A

OLEMA PHARMACEUTICALS INC / OLMA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of OLEMA PHARMACEUTICALS INC (OLMA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to OLMA.


What is the valuation status of OLEMA PHARMACEUTICALS INC (OLMA) stock?

ChartMill assigns a valuation rating of 0 / 10 to OLEMA PHARMACEUTICALS INC (OLMA). This can be considered as Overvalued.


How profitable is OLEMA PHARMACEUTICALS INC (OLMA) stock?

OLEMA PHARMACEUTICALS INC (OLMA) has a profitability rating of 1 / 10.


What is the earnings growth outlook for OLEMA PHARMACEUTICALS INC?

The Earnings per Share (EPS) of OLEMA PHARMACEUTICALS INC (OLMA) is expected to decline by -23.94% in the next year.